They further confirmed that ERBB3 silencing decreased PI3K and AKT phosphorylation upregulated by HOXC10 and significantly reduced esophageal squamous cell carcinoma cells proliferative capacity (52). This evidence concerns the gene AKT1 and esophageal squamous cell carcinoma.